Mesenchymal Stem Cells (MSCs) therapy(Shenzhen Geno-Immune Medical Institute)

N/A

Report date: 2026/03/19 20:00:18

Base Information

Drug NameMesenchymal Stem Cells (MSCs) therapy(Shenzhen Geno-Immune Medical Institute)

Drug Alias NameN/A

ClassificationCell and gene therapy > Cell therapy > Stem cell therapy > Mesenchymal stem cells therapyCell and gene therapy > Cell therapy > Source of cells > Fetal-derived

Mechanisms of ActionStem cell replacements

TargetsNot applicable

Therapy Area/IndicationsAutoimmune Diseases

Global Approved IndicationsN/A

Approved Indications in ChinaN/A

Original Approved Country/TerritoryN/A

Original Approved DateN/A

Country/TerritoryMainland China

CombinationsNo

Global Highest StatusPhase 2 Clinical

Highest Status in ChinaPhase 2 Clinical

Originator CompaniesShenzhen Geno-Immune Medical Institute

China Registration ClassN/A

Develop Information

Active CompaniesShenzhen Geno-Immune Medical Institute

Inactive CompaniesN/A

Active IndicationsAutoimmune Diseases

Inactive IndicationsN/A

Other Information

ATC CodeN/A